Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study
TACE联合乐伐替尼和PD-1抑制剂治疗超过UP-7标准的中晚期肝细胞癌的疗效和安全性:一项回顾性队列研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1560750
Xue, Miao; Wu, Yanqin; Tang, Yiyang; Huang, Kun; Liu, Haikuan; Zhu, Bowen; Wen, Jie; Zhao, Yue; Zhang, Guixiong; Liu, Hang; Fan, Wenzhe; Li, Jiaping